You can access any of the podium or poster presentations’ abstracts by searching for it below.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Switchability of drug products: scientists vs. lawmakers
- In: Moving forward drug product Quality (SIG Bioavailability/Bioequivalence) on Tuesday, 7 September 2004, 9:00-12:00
- At: New Orleans (USA) (2004)
- Type: Presentation
- By: DRESSMAN, Jennifer (Institute of Pharmaceutical Technology, J.W. Goethe University, Frankfurt Am Main, Germany)
- Abstract:
For many years now, regulations have been in place setting out the requirements for generic substitution of drug products. Important requirements include pharmaceutical equivalence, bioequivalence and therapeutic equivalence of the generic product with the reference product. While various authorities differ slightly in their definitions of
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 2 July 2026